SCHEMBL21351398

SCHEMBL21351398

c1ccc(-c2ccc(-c3ncc4c(n3)c3nc(-n5c6ccccc6c6ccccc65)ncc3c3c5ccccc5c5ccccc5c43)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.40
▸ RAB9A P51151 3/20 0.40
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ MAPT P10636 2/20 0.40
▸ LMNA P02545 1/20 0.40
▸ RECQL P46063 1/20 0.40
▸ NFKB1 P19838 2/20 0.35
▸ NFKB2 Q00653 2/20 0.35
▸ RELA Q04206 2/20 0.35
▸ MTOR P42345 3/20 0.33
▸ TLR7 Q9NYK1 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ ATM Q13315 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ KMT2A Q03164 3/20 0.31
▸ PTK2B Q14289 1/20 0.30
▸ NPSR1 Q6W5P4 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21351372 0.97 NPC1 (0.41) NPC1RAB9ASMN1; SMN2MAPTLMNA
SCHEMBL21351136 0.94 NPC1 (0.42) NPC1RAB9ASMN1; SMN2MAPTLMNA
SCHEMBL21351425 0.90 NPC1 (0.33) NPC1RAB9ASMN1; SMN2MAPTLMNA
SCHEMBL21351280 0.89 NPC1 (0.31) NPC1RAB9ASMN1; SMN2MAPTLMNA
SCHEMBL21351376 0.88 NPC1 (0.38) NPC1RAB9ASMN1; SMN2MAPTLMNA
SCHEMBL21351394 0.88 NPC1 (0.38) NPC1RAB9ASMN1; SMN2MAPTLMNA
SCHEMBL21351396 0.87 KDM4E (0.37) KDM4EATML3MBTL1HPGD
SCHEMBL21351375 0.86 NPC1 (0.42) NPC1RAB9ASMN1; SMN2MAPTLMNA
SCHEMBL21351374 0.85 NPC1 (0.38) NPC1RAB9ASMN1; SMN2MAPTLMNA
SCHEMBL21351405 0.85 NPC1 (0.51) NPC1RAB9ASMN1; SMN2MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190280214-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2019-09-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190280214-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES LEF1, OCIAD1, OCIAD2 NPC1 1575/4885RAB9A 375/4885SMN1; SMN2 3926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback